Jin Medical International First Half 2025 Earnings: US$0.001 loss per share (vs US$0.011 profit in 1H 2024)

Jin Medical International (NASDAQ:ZJYL) First Half 2025 Results

Key Financial Results

• Revenue: US$9.88m (down 6.4% from 1H 2024).
• Net loss: US$89.0k (down by 105% from US$1.79m profit in 1H 2024).
• US$0.001 loss per share (down from US$0.011 profit in 1H 2024).

We've found 21 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free.

All figures shown in the chart above are for the trailing 12 month (TTM) period

Jin Medical International shares are up 18% from a week ago.

Risk Analysis

Be aware that Jin Medical International is showing 4 warning signs in our investment analysis and 1 of those shouldn't be ignored...

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.